Hypomethylating Agents in Oncohematology

by AD Shirin, OYu Baranova
Published 2016-10-01

NK-Cell Lymphoblastic Leukemia/Lymphoma (Literature Review and Authors’ Experience)

by MA Frenkel’, OYu Baranova, AS Antipova, NA Kupryshina, NN Tupitsyn
Published 2016-04-01

Evaluation of Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Using EuroFlow Approaches

by OA Beznos, LYu Grivtsova, AV Popa, MA Shervashidze, IN Serebryakova, OYu Baranova, EA Osmanov, NN Tupitsyn
Published 2017-04-01

Molecular Genetic Abnormalities in the Pathogenesis of Hematologic Malignancies and Corresponding Changes in Cell Signaling Systems

by LR Tilova, AV Savinkova, EM Zhidkova, OI Borisova, TI Fetisov, KA Kuzin, OA Vlasova, AS Antipova, OYu Baranova, KI Kirsanov, GA Belitskii, MG Yakubovskaya, EA Lesovaya,5
Published 2017-04-01

Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia: Russian Multicenter Clinical Trial

by SN Bondarenko, EN Parovichnikova, AA Maschan, OYu Baranova, TV Shelekhova, VA Doronin, VYa Mel’nichenko, KD Kaplanov, OS Uspenskaya, AN Sokolov, NV Myakova, IS Moiseev, IV Markova, EI Darskaya, AG Smirnova, TA Bykova, BI Ayubova, IA Samorodova, EV Babenko, IM Barkhatov, TL Gindina, AD Kulagin, BV Afanas’ev
Published 2019-03-01